Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schram

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Blood Advances|March 10, 2020
Identification of germline variants in adults with hemophagocytic lymphohistiocytosisPeter G Miller, Abhishek Niroula, John J Ceremsak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug developmentC B Westphalen, D Martins-Branco, J R Beal, et al.
Nature Genetics|July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancersCraig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Nature Communications|April 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivitiesTripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 TrialAlison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Blood|September 22, 2020
Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosisPeter G Miller, Adam S Sperling, Christopher J Gibson, et al.
NPJ Precision Oncology|February 14, 2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapyCharlotte S Walmsley, Philip Jonsson, Michael L Cheng, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Blood Advances|March 10, 2020
Identification of germline variants in adults with hemophagocytic lymphohistiocytosisPeter G Miller, Abhishek Niroula, John J Ceremsak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug developmentC B Westphalen, D Martins-Branco, J R Beal, et al.
Nature Genetics|July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancersCraig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Nature Communications|April 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivitiesTripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 TrialAlison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Blood|September 22, 2020
Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosisPeter G Miller, Adam S Sperling, Christopher J Gibson, et al.
NPJ Precision Oncology|February 14, 2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapyCharlotte S Walmsley, Philip Jonsson, Michael L Cheng, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
Pageof 19